Lumida
/LUCD
⌘K
Lucid Diagnostics Inc

Lucid Diagnostics Inc

LUCD
$0.99USD↑+1.62%+0.02 today

MARKET CAP

201.2M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$1 – $1

52W RANGE

$1
$2

AI Summary

Stalk
Sell NowMedium

LUCD remains in a clear Stage 4 downtrend with persistent lower-high/lower-low structure and price rejected at falling EMAs. The medium-term bias is bearish under distribution dynamics, and tactical timing favors selling on bounce attempts into resistance. On the short term, recent rallies into the 9/21 EMA have failed and RSI remains oversold, supporting an immediate sell posture. The primary risk is a shallow exhaustion-driven bounce that could trap sellers before continuation. Bearish bias would be invalidated by a sustained daily close back above the 21 EMA and the last lower high.

  • ↑BTIG Research assigns a “Buy” rating, signaling strong analyst support
  • ↑Potential Medicare coverage could drive significant volume and revenue growth
  • ↓Q2 revenue $1.5M offset by widening losses and –50% EPS surprise
Full analysis →

Buying

4

institutions

Selling

2

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY8.37 M8.96 M+3.73 M+68.0%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY723.20 K773.82 K+488.43 K+186.6%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL71.30 K76.29 K+-428.36 K-86.7%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY62.77 K65.91 K+7.13 K+3.0%0.00%
CA

Citadel Advisors LLC

Q2 2026

BUYNEW36.36 K38.91 K+36.36 K+0.0%0.00%
MM

Millennium Management LLC

Q2 2026

SELL0.000.00+-11.32 K-100.0%0.00%